Position in MRK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,128,101
+$50,544 QoQ
Shares Held
8,779
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#2,017
of 3,768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investors Research Corp holds $5,482,615 across 10 Drug Manufacturers - General names. MRK ranks #1 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
8,779 | $1,128,101 | |
| 2 | PFE |
Pfizer Inc
|
38,962 | $938,204 | |
| 3 | NVO |
Novo Nordisk A S
|
18,225 | $873,706 | |
| 4 | GSK |
GSK plc
|
14,952 | $783,783 | |
| 5 | SNY |
Sanofi
|
16,468 | $702,524 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,628 | $497,145 | |
| 7 | BIIB |
Biogen Inc.
|
1,641 | $354,554 | |
| 8 | AZN |
Astrazeneca PLC
|
642 | $121,736 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,128,101 | 8,779 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,077,557 | 8,958 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $981,549 | 9,325 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $782,647 | 9,325 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $728,667 | 9,205 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $826,240 | 9,205 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $900,791 | 9,055 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,042,026 | 9,176 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,135,988 | 9,176 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,210,773 | 9,176 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,796,976 | 16,483 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,696,924 | 16,483 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,901,973 | 16,483 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,872,144 | 17,597 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,985,672 | 17,897 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,556,360 | 18,072 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,640,148 | 17,990 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,472,305 | 17,944 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $864,192 | 11,276 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $846,940 | 11,276 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $876,934 | 11,276 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $857,703 | 11,126 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $910,106 | 11,126 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $922,902 | 11,126 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $860,373 | 11,126 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $856,034 | 11,126 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||